Astrana Health, Inc. (ASTH)
Astrana Health, Inc. (ASTH) from its SEC filings: 2025 revenue $3.2 billion (+56% vs the year before), net margin 1%, free cash flow $104.5 million. Insider trades, recent filings and a price chart. Free.
| Exchange | Nasdaq |
| Industry | Services-Management Consulting Services |
| Revenue (2025) | $3.2 billion |
| Revenue growth | +56% |
| Net income | $24.0 million |
| Net margin | 0.8% |
| Free cash flow | $104.5 million |
| Diluted EPS | $0.46 |
| Latest quarter (Q2 2026 (calendar)) revenue vs a year earlier | +48% |
| Cash | $400.8 million |
| Long-term debt | $882.6 million |
| Share count, 1 year | -1% |
| Fundamentals check | Strong fundamentals |
Source: SEC EDGAR company filings (XBRL), updated 2026-10-24. Education only, not financial advice.